Pharmacodynamic effects of the oral glucokinase activator AZD6370 after single doses in healthy volunteers assessed with euglycaemic clamp.
Phase of Trial: Phase I
Latest Information Update: 13 Aug 2013
At a glance
- Drugs AZD 6370 (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 13 Aug 2013 New trial record